In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Cardiogenic shock: recent advances and future perspectives
Session

Event : Heart Failure 2019

Topic : Acute Heart Failure - Clinical

  • Session type : Symposium
  • Date : 26 May 2019
  • Time : 16:15 - 17:45

4 presentations in this session

Definition and clinical phenotypes.

Event : Heart Failure 2019

  • Session : Cardiogenic shock: recent advances and future perspectives
  • Speaker : A Mebazaa (Paris,FR)

Risk stratification.

Event : Heart Failure 2019

  • Session : Cardiogenic shock: recent advances and future perspectives
  • Speaker : V Harjola (Helsinki,FI)

Medical therapy.

Event : Heart Failure 2019

  • Session : Cardiogenic shock: recent advances and future perspectives
  • Speaker : JT Parissis (Athens,GR)

Interventions and mechanical circulatory support.

Event : Heart Failure 2019

  • Session : Cardiogenic shock: recent advances and future perspectives
  • Speaker : D Milicic (Zagreb,HR)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are